Clinical Trial Update: Study of Combined Topical Growth Factor and Protease Inhibitor in Chronic Wound Healing [Phase 3]

View source ↗

Summary

This document provides an update on a Phase 3 clinical trial evaluating a combination of topical growth factor and protease inhibitor for chronic wound healing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer
• Venous Ulcers

Drugs mentioned

• Topical growth factor and protease inhibitor (combination therapy)

Snippet

Sponsor: McMaster University | Conditions: Venous Ulcer, Foot Ulcer, Diabetic | Phase 3 | Status: UNKNOWN